Market Closed -
Swiss Exchange
11:30:04 2024-10-09 am EDT
5-day change
1st Jan Change
123.40 CHF
0.00%
0.00%
-1.75%
Capitalization
2.62B
2.86B
2.46B
P/E ratio 2024 *
36.9x
P/E ratio 2025 *
30.9x Enterprise value
2.75B
3.01B
2.59B
EV / Sales 2024 *
4.75x
EV / Sales 2025 *
4.15x Free-Float
30.01%
Yield 2024 *
0.57%
Yield 2025 *
0.68%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Swiss Market Index Advances Ahead of SNB's Rate Decision Day
Sep. 25
MT
Medacta Group SA - Analyst/Investor Day
Sep. 25
Medacta Group Reports Growth in H1 Attributable Profit, Revenue
Sep. 25
MT
Medacta's Profitability at Risk Amid Expected Sales Slowdown in H1, Morgan Stanley Says
Sep. 24
MT
Medacta Group SA Reports Earnings Results for the Half Year Ended June 30, 2024
Sep. 23
CI
Medacta Group, Think Surgical Partner in US for Robotic Total Knee Arthroplasty Solution
Aug. 30
MT
Medacta Group, Mighty Oak Medical Settle Patent Dispute via New License Deal
Aug. 28
MT
Medacta Group SA, H1 2024 Earnings Call, Jul 25, 2024
Jul. 25
Medacta Group SA Proposes Distribution
Mar. 13
CI
Medacta Group SA Provides Earnings Guidance for the Year 2024
Mar. 13
CI
Medacta Group SA, 2023 Earnings Call, Mar 13, 2024
Mar. 13
Medacta Group Records Higher FY23 Attributable Profit, Revenue
Mar. 13
MT
Medacta Group SA Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 12
CI
More news
1 week +0.82%
Current month -1.28%
3 months +1.82%
6 months +5.29%
Current year -1.75%
More quotes
Director
Title Age Since
Chief Executive Officer
47
18-10-31
Director of Finance/CFO
56
07-12-31
Sales & Marketing
-
-
Manager
Title Age Since
Founder
80
98-12-31
Director/Board Member
49
17-12-31
Director/Board Member
67
18-12-31
More insiders
2024 * 2025 * Net sales
580M
634M
546M
664M
727M
625M
Net income
70.88M
77.53M
66.73M
84.58M
92.52M
79.63M
Net Debt
138M
151M
130M
137M
150M
129M
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
More about the company
Date
Price
Change
Volume
24-10-09
123.40
CHF
0.00%
6,248
24-10-08
123.40
CHF
-3.29%
7,283
24-10-07
127.60
CHF
+2.41%
8,172
24-10-04
124.60
CHF
+2.13%
8,304
24-10-03
122.00
CHF
-1.13%
7,592
Delayed Quote
Swiss Exchange, October 09, 2024 at 11:30 am EDT
More quotes
Last Close Price
131.17 EUR
Average target price
147.00 EUR
Spread / Average Target
+12.07%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1